We reiterate our BUY rating despite trimming our TP by 5.3% as we exclude Singha’s remaining investment of USD450 million from our valuation. TP would have stayed the same otherwise. Nutri-Science (revenue +18% in 9M 2016, +15% in FY17F) leads growth with